How we are funded
As part of the European Molecular Biology Laboratory (EMBL), the largest part of our funding comes from the governments of EMBL’s member states. The global importance of our work is reflected in the fact that we also attract significant funds from external sources, including some beyond Europe.
Other major funders include the UK Research and Innovation (UKRI), via the UK’s Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council, as well as the European Commission, the US National Institutes of Health, the Wellcome Trust, and members of our Industry Programme.
The UK’s Biotechnology and Biological Sciences Research Council (BBSRC) has awarded major grants in support of EMBL-EBI’s role as a host to the ELIXIR Hub and a key ELIXIR Node. These funds have been used to develop a robust compute infrastructure that will allow EMBL-EBI to efficiently manage an ever-expanding and diversifying range of public data services.
Read about our achievements, growth, funding and staff in our latest report.
With thanks to our funders
We gratefully acknowledge the continued support of EMBL member states and other funding organisations. Our funders make it possible for us to deliver open data resources, perform excellent research and provide professional training for the global scientific community. In 2017 our funders included:
- Australian National Health and Medical Research Council
- Biotechnology and Biological Sciences Research Council
- British Council
- British Heart Foundation
- Cancer Research UK
- Chan Zuckerberg Initiative
- European Commission
- European Molecular Biology Organisation
- European Research Council
- Foundation of the National Institutes of Health
- Bill & Melinda Gates Foundation
- Gordon and Betty Moore Foundation
- Human Frontier Science Program
- Innovate UK
- Medical Research Council
- National Institutes of Health
- National Science Foundation
- Research Councils UK
- Wellcome Trust